EP1542945A2 - Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques - Google Patents

Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques

Info

Publication number
EP1542945A2
EP1542945A2 EP03792347A EP03792347A EP1542945A2 EP 1542945 A2 EP1542945 A2 EP 1542945A2 EP 03792347 A EP03792347 A EP 03792347A EP 03792347 A EP03792347 A EP 03792347A EP 1542945 A2 EP1542945 A2 EP 1542945A2
Authority
EP
European Patent Office
Prior art keywords
cyclase
plant
promoter
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03792347A
Other languages
German (de)
English (en)
Inventor
Christel Renate Schopfer
Ralf Flachmann
Karin Herbers
Irene Kunze
Matt Sauer
Martin Klebsattel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SunGene GmbH
Original Assignee
SunGene GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10238979A external-priority patent/DE10238979A1/de
Priority claimed from DE2002138980 external-priority patent/DE10238980A1/de
Priority claimed from DE10238978A external-priority patent/DE10238978A1/de
Priority claimed from DE2002153112 external-priority patent/DE10253112A1/de
Priority claimed from DE2002158971 external-priority patent/DE10258971A1/de
Application filed by SunGene GmbH filed Critical SunGene GmbH
Publication of EP1542945A2 publication Critical patent/EP1542945A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B61/00—Dyes of natural origin prepared from natural sources, e.g. vegetable sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Definitions

  • the present invention relates to a process for the preparation of zeaxanthin and / or its biosynthetic intermediates and / or secondary products by cultivating genetically modified plants which, compared to the wild type, have a reduced ⁇ -cyclase sequence caused by double-stranded ⁇ -cyclase-ribonucleic acid sequences. Have activity, the genetically modified plants, and their use as food and feed and for the production of carotenoid extracts. , "
  • the ⁇ -cyclase activity in plants can be reduced compared to the wild type, for example by reducing the amount of ⁇ -cyclase protein or the amount of ⁇ -cyclase mRNA in the plant. Accordingly, ⁇ -cyclase activity which is reduced compared to the wild type can be determined directly or by determining the amount of ⁇ -cyclase protein or the ⁇ -cyclase mRNA merige of the plant according to the invention in comparison to the wild type.
  • ⁇ -cyclase activity in genetically modified plants according to the invention and in wild-type or reference plants is preferably carried out under the following conditions:
  • plant can be understood to mean the starting plant (wild type) or a genetically modified plant according to the invention or both.
  • the ⁇ -cyclase activity is reduced by introducing at least one double-stranded ⁇ -cyclase ribonucleic acid sequence, hereinafter also called ⁇ -cyclase dsRNA, or an expression cassette or expression cassette ensuring its expression in plants.
  • ⁇ -cyclase dsRNA double-stranded ⁇ -cyclase ribonucleic acid sequence
  • the ratio of double-stranded molecules to corresponding dissociated forms is preferably at least 1 to 10, preferably 1: 1, particularly preferably 5: 1, most preferably 10: 1.
  • b) is identical to at least part of the plant's own ⁇ -cyclase promoter sequence.
  • RNA the "at least a part of the plant's ⁇ -cyclase promoter sequence identical" is preferably meant that the RNA sequence with at least a portion of the theo- retical transcript 15 'of the ⁇ -cyclase promoter Sequence, .also the corresponding RNA sequence, is identical.
  • the ⁇ -cyclase dsRNA therefore contains a sequence which is identical to a part of the plant's own ⁇ -cyclase transcripts and which codes for the 5th ⁇ end or the 3 ⁇ end of the plant's own nucleic acid contains an ⁇ -cyclase.
  • non-translated areas are in the 5 * or
  • the ⁇ -cyclase-nucleic acid sequence or the corresponding transcript is preferred
  • an "essentially identical" dsRNA can also be defined as a nucleic acid sequence which is capable of hybridizing with part of an ⁇ -cyclase gene transcript, for example in 400 mM NaCl, 40 mM PIPES pH 6.4, 1 mM EDTA at 50 ° C or 70 ° C for 12 to 16 h).
  • the present invention therefore also relates to a “ nucleic acid construct that can be transcribed into
  • RNA strand comprising at least one ribonucleotide sequence which is essentially identical to at least part of the “sense” RNA ⁇ -cyclase transcript
  • RNA strand which is essentially — preferably completely — complementary to the RNA sense strand under a).
  • the following partial sequences are particularly preferably used, in particular for Tagetes erecta:
  • SEQ. ID. NO. 6 Sense fragment of the 5'-terminal region of the ⁇ -cyclase
  • SEQ. ID. No. 14 Antisense fragment of the ⁇ -cyclase promoter
  • the dsRNA can be introduced in an amount that enables at least one copy per cell. Larger quantities (e.g. at least 5, 10, 100, 500 or 1000 copies per cell) can possibly result in an efficient reduction.
  • a plant selected from the plant genera Marigold, Tagetes, Acacia, Aconituim, Adonis, Arnica, Aquilegia, Aster, Astragalus, Bignonia, Calendula, Caltha, Campanula, Canna, Centaurea, Cheiranthus, Chrysanthemum, Citrus is particularly preferably used as the plant , Crepis, Crocus, Curcurbita, Cytisus, Delonia, Delphinium, Dianthus, Dimorphotheca, Doronicum,
  • the transgenic plants are grown on nutrient media in a manner known per se and harvested accordingly.
  • Zeaxanthin and / or its biosynthetic intermediate and / or secondary products are isolated from the harvested petals in a manner known per se, for example by drying and subsequent extraction and, if appropriate, further rer chemical or physical "" cleaning processes, such as precipitation methods, crystallography, thermal separation processes, such as rectification processes or physical separation processes, such as chromatography.
  • Zeaxanthin and / or its biosynthetic intermediate and / or secondary products are isolated from the petals, for example, preferably by organic solvents such as acetone, hexane, ether or tert. Methyl butyl ether.
  • ketocarotenoids in particular from petals, are described, for example, in Egger and Kleinig (Phytochemistry (1967) 6, 437-440) and Egger (Phytochemistry (1965) 4, 609-618).
  • Pathogen-inducible promoters include those of genes induced by pathogen attack such as genes from PR proteins, SAR proteins, b-1, 3-glucanase, chitinase etc. (e.g. Redolfi et al. (1983) Neth J Plant Pathol 89: 245-254; Uknes, et al. (1992) The Plant Cell 4: 645-656; Van Loön (1985) Plant Mol Viral 4: 111-116; Marineau et.al. (1987) Plant Mol -Biol 9: 335-342; Matton et al ' ._ (1987) Molecülar Plant-Microbe Interactions 2: 325-342; Somssich et al.
  • wound-inducible engines such as the pinll gene (Ryan (1990) Ann Rev Phytopath 28: 425-449; Duan et al. (1996) Nat Biotech 14: 494-498), the wunl and wun2 genes (US 5,428,148), the winl and win2 genes (Stanford et al. (1989) Mol Gen Genet 215: 200-208), the systemin (McGurl et al. (1992) Science 225: 1570-1573), the WIPl gene (Rohmeier et al. (1993) Plant Mol Biol 22: 783-792; Ekelkamp et al. (1993) FEBS Letters 323: 73-76), the MPI gene (Corderok et al. (1994) The Plant J 6 ( 2) .141-150) and the like.
  • the pinll gene Rost al. (1990) Ann Rev Phytopath 28: 425-449; Duan et al. (1996) Nat Biotech 14: 494
  • promoters are particularly preferred which ensure expression in tissues or parts of plants in which, for example, the biosynthesis of ketocarotenoids or their precursors takes place.
  • promoters with specificities for the anthers, ovaries, petals, sepals, flowers, leaves, stems and roots and combinations thereof are preferred.
  • Tuber-, storage root- or root-specific promoters are, for example, the " Class I Patatin Promoter (B33) or the potato cathepsin D inhibitor promoter.
  • the construct to be expressed is preferably cloned into a vector which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. " Acids Res. 12 (1984), 8711) " or particularly preferably pSUN2, pSUN3, pSUN4 or pSUN5 (WO 02/00900).
  • transgenic plants can be regenerated in a known manner which contain a gene encoding a ketolase for the expression of a nucleic acid encoding the expression cassette.
  • an expression cassette is incorporated as an insert into a recombinant vector whose vector DNA comprises additional functional regulatory signals, examples play example sequences for replication or integration. Suitable vectors are described in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, pp. 71-119 (1993).
  • the genetically modified plants can, as described above, for the production of zeaxanthin and / or its biosynthetic intermediates and / or secondary products, in particular for the production of lycopene, ⁇ -carotene, astaxanthin, canthaxanthin, echinenone, 3-hydroxyechinenone, 3 'Hydroxyechinenone, adonirubin or adonixanthin and in particular for the production of astaxanthin can be used.
  • an increased content is also understood to mean a caused content of ketocarotenoids or astaxanthin.
  • Genetically modified plants according to the invention which are edible by humans and animals and have an increased content of zeaxanthin and / or its biosynthetic intermediate and / or secondary products can also be used, for example, directly or after processing known per se as food or feed or as feed and food supplements , Furthermore, the genetically modified plants can be used for the production of carotenoid-containing extracts of the plants and / or for the production of feed and food supplements.
  • the genetically modified plants can ⁇ . can also be used as ornamental plants in the horticulture sector.
  • FIG. 5 is not restricted to these:
  • inverted repeat transcripts consisting of - . Fragments of the epsilon cyclase in Tagetes erecta were carried out under the control of a modified version AP3P of the flower-specific promoter AP3 from Arabidopsis thaliana (AL132971: nucleotide region 25 9298-10200; Hill et al. (1998) Development 125: 1711-1721)
  • the PCR for the amplification of the DNA encoding the AP3 promoter fragment was carried out in a 50 1 reaction mixture which contained: 45 - 1 ul genomic DNA from ' A. tanne.liana (1: 100 dil prepared as described above) 0.25 mM dNTPs
  • the 922 bp amplificate was cloned into the PCR cloning vector pCR 2.1 (invi rogen) using standard methods
  • Sequencing of the clone pTAP3 confirmed a sequence consisting only of an insertion (a G in position 9765 of the sequence AL132971) and a base exchange (a G instead of an A in position 9726 of the sequence AL132971) from the published AP3 sequence (AL132971 , Nucleotide region
  • the modified version AP3P was produced by means of recombinant PCR using the plasmid pTAP3.
  • the region 10200-9771 was amplified with the primers PR7 (SEQ ID No. 15) and primers PR9 (SEQ ID No. 17) (amplificate A7 / 9), the 35 region 9526-9285 with the PR8 (SEQ ID No. 16). and PR10 (SEQ ID No. 18) amplified (amplificate A8 / 10).
  • the cloning was carried out by isolating the 771 bp SacI-HindIII fragment from pTAP3P and ligating into the SacI-HindIII cut vector pJITH7.
  • the clone that contains the AP3P promoter instead of the original d35S promoter is called pJAP3P.
  • the PCR conditions were as follows:
  • the PCR for the amplification of the sequence of the intron PIV2 of the ST-LS1 gene was carried out in a 50 1 reaction which contained: - 1 ⁇ l p35SGUS INT
  • PCR amplification using primers PR42 and PR43 resulted 'in a 443 bp fragment
  • PCR amplification using primers PR44 and PR45 resulted in a 444 bp fragment.
  • a CHRC promoter fragment using genomic DNA from petunia (prepared according to standard methods) and the primers PRCHRC5 (SEQ ID No. 42) and PRCHRC3 (SEQ ID No. 43) amplified.
  • the amplificate was cloned into the cloning vector pCR2.1 (Invitrogen). Sequencing of the resulting clone pCR2.1-CHRC with the primers M13 and T7 confirmed a sequence identical to the sequence AF099501. This clone was therefore used for the cloning into the expression vector pJAl3.
  • Total RNA was prepared from Tagetes flowers as described in Example 2.
  • the PCR for the amplification of the PR46-PR457 DNA fragment which contains the 3'-terminal 384 bp region of the epsilon cyclase, was carried out in a 50 ⁇ l reaction mixture which contained:
  • PCR amplification with SEQ ID No.26 and SEQ ID No. ' 27 resulted in a 392 bp fragment
  • the PCR amplification with SEQ ID No.28 and SEQ ID No. 29 resulted in a 396 bp fragment.
  • the first cloning step was carried out by isolating the 396 bp PR48-PR49 BamHI-EcoRI fragment from the cloning vector pCR-BluntII (Invitrogen) and ligation with the BamHI-EcoRI cut vector pJAIl.
  • the clone that contains the terminal region of the epsilon cyclase in the antisense orientation is called pJAl4.
  • the ligation results in a transcriptional fusion between the antisense fragment of the 3'-terminal region of the epsilon cyclase and the polyadenylation signal from CaMV.
  • fragment AP3P contains the modified AP3P promoter (771 bp), fragment sense the 3 'region of the Epsilon cyclase from Tagetes erecta . (435 bp) in sense orientation, fragment intron the intron ' IV2 of the potato gene ST-LSI / fragment anti the 3' region of the Epsilon cyclase from Tagetes erecta (435 bp) in "antisense orientation, and fragment term ( 761 bp) the poly-adenylation signal of CaMV.
  • the PCR for the amplification of the PR50-PR51 DNA fragment which contains, among other things, the 312 bp promoter fragment of epsilon cyclase, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the amplificate was cloned into the PCR cloning vector pCR2.1 (Invitrogen) using standard methods. Sequencing with the primers M13 and T7 resulted in the sequence SEQ ID No. 11. This sequence was reproduced in an independent amplification experiment and thus represents the nucleotide sequence in the Tagetes erecta Orange Prince line used.
  • ADl initially represented a mixture of primers of the sequences (a / c / g / t) tcga (g / c) t (a / t) t (g / c) g (a / t) gtt.
  • the PCR reaction TAIL1 was carried out under the following cycle conditions:
  • the TAIL3-PCR was carried out in a 100 ⁇ l reaction mixture, which contained:
  • the PCR reaction TAIL3 was carried out under the following cycle conditions; 20X 94 ° C: 15 seconds, 29 ° C: 30 seconds, 72 ° C: 2 minutes IX 72 ° C: 5 minutes
  • the amplificate was cloned into the PCR cloning vector pCR2.1 (Invitrogen) using standard methods. Sequencing with the primers Ml3 and T7 resulted in the sequence SEQ ID No. 12. This sequence is identical to the ecyclase region within the sequence SEQ ID No. 11, which was isolated with the IPCR strategy, and thus represents the nucleotide sequence in the Tagetes erecta line Orange Prince used.
  • the promoter fragments were PCR by means of plasmid DNA (clone pTA-ecycP, see Example 4) and the primers PR124 (SEQ ID No. 36) and PR126 (SEQ ID No. 38) or the primer PR125 (SEQ ID No 37) and PR127 (SEQ ID No. 39).
  • the conditions of the PCR reactions were as follows: The PCR for the amplification of the PR1 4-PR12.6_ DNA fragment, which contains the promoter fragment from the epsilon cyclase, was carried out in a 50 ⁇ l reaction mixture which contained:
  • PCR amplification with primers PR124 and PR126 resulted in a 358 bp fragment
  • PCR amplification with primers PR125 and PR127 resulted in a 361 bp fragment.
  • the two amplicons were cloned into the PCR cloning vector pCR-BluntII (Invitrogen) using standard methods. Sequencing with the primer SP6 each confirmed a sequence which, apart from the restriction sites introduced, is identical to SEQ ID No. 11. These clones were therefore used for the production of an inverted repeat construct in the cloning vector pJAII (see example 1).
  • the first cloning step was carried out by isolating the 358 bp PR124-PR126 HindIII-SalI fragment from the cloning vector pCR-BluntII (Invitrogen) and ligation with the BamHI-EcoRI cut vector pJAII.
  • the clone that contains the epsilon cyclase promoter fragment in the sense orientation is called cs43.
  • the sense fragment of the epsilon cyclase promoter is inserted between the AP3P promoter and the intron by the ligation.
  • the second cloning step was carried out by isolating the 36 lbp PR125-PR127 BamHI-EcoRI fragment from the cloning vector pCR-BluntII (Invitrogen) and ligation with BamHI-EcoRI cut vector cs43.
  • the clone that contains the epsilon cyclase promoter fragment in the antisense orientation is called cs44.
  • the ligation creates a transcriptional fusion between the intron and antisense fragments of the epsilon cyclase promoter.
  • the AP3P promoter was cloned in cs45 in antisense orientation at the 3'terminus of the epsilon-cyclase antisense fragment.
  • the AP3P promoter fragment from pJAII was amplified using the primers PR128 and PR129.
  • the amplificate was cloned into the cloning vector pCR2.1 (Invitrogen).
  • the sequencing with the primers M13 and T7 confirmed a sequence SEQ ID No. 1 identical sequence ..
  • the expression vectors for the Agrobacterium -mediated transformation of the AP3P-controlled inverted repeat transcript in Tagetes erecta were produced using the binary vector pSUN5 (WO02 / 00900).
  • fragment CHRC contains the CHRC promoter (1537 bp), fragment P-sense the 312 bp promoter fragment of epsilon cyclase in sense orientation, fragment intron the intron IV2 of the potato gene ST-LSI), and fragment P- anti the 312 bp promoter fragment of the epsilon cyclase in antisense orientation.
  • fragment CHRC contains the CHRC promoter (1537 bp), fragment P-sense the 312 bp promoter fragment of epsilon cyclase in sense orientation, fragment intron the intron IV2 of the potato gene ST-LSI), fragment P-anti the 312 bp promoter fragment of the epsilon cyclase in antisense orientation and the fragment AP3P the 771 bp AP3P promoter fragment in antisense orientation.
  • Example 6 Production of transgenic plants
  • germination medium MS medium; Murashige and Skoog, Physiol. Plant. 15 (1962), 5 473-497) pH 5.8, 2% sucrose). Germination takes place in a temperature / light / time interval of 18 to 28 ° C / 20 to 200 for 4 to 8 weeks.
  • the Agrobacterium tumefaciens strain EHA105 was treated with 'the binary plasmid pS5AI3 transformed. Culturing of the transformed A. tumefaciens strain EHA105 was grown overnight under the following conditions: A single colony was inoculated into YEB (0.1% yeast extract.
  • the MS medium in which the leaves have been stored is replaced by the bacterial suspension
  • the explants are cultivated for 1 to 8 days, but preferably for 6 days, the following conditions being able to be used: light intensity: 30 to 80 ocmol / m 2 x sec, temperature:
  • the co-cultivated explants are then transferred to fresh MS medium, preferably with the same growth regulators, this second medium additionally containing an antibiotic to suppress bacterial growth.
  • the explants are transferred to fresh medium until shoot buds and small shoots develop, which are then on the same basal medium including timentin and PPT or alternative components with growth regulators, namely, for example, 0.5 mg / 1 indolylbutyric acid (IBA) and 0.5 mg / 1 gibberillic acid GA 3 , are transferred for rooting. Rooted shoots can be transferred to the greenhouse.
  • IBA indolylbutyric acid
  • GA 3 gibberillic acid
  • the explants. Before the explants. can be infected with the bacteria, +. NEN for 1 to 12 days, preferably 3 to 4, on the. medium for the co-culture described above are pre-incubated. The infection, co-culture and selective regeneration then take place as described above.
  • Liquid culture medium can also be used for the entire process.
  • the culture can also be incubated on commercially available carriers which are positioned on the liquid medium.
  • the flower material of the transgenic Tagetes erecta plants from Example 6 was mortarized in liquid nitrogen and the powder (about 250 to 500 mg) extracted with 100% acetone (three times 500 ul each). The solvent was evaporated and the carotenoids resuspended in 100 ul acetone.
  • the genetically modified plants Compared to the genetically unmodified control plant, the genetically modified plants have a significantly increased content of carotenoids of the " ⁇ -carotene pathway", such as, for example, ⁇ -carotene and zeaxanthin, and a significantly reduced content of carotenoids of the " ⁇ -carotene pathway” , such as lutein.
  • ⁇ -carotene pathway such as, for example, ⁇ -carotene and zeaxanthin
  • ⁇ -carotenoids of the " ⁇ -carotene pathway” such as lutein.
  • Comparative Example 1 Reduction of the ⁇ -cyclase activity in Tagetes erecta by antisense

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fodder In General (AREA)
EP03792347A 2002-08-20 2003-08-18 Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques Withdrawn EP1542945A2 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DE10238980 2002-08-20
DE10238979A DE10238979A1 (de) 2002-08-20 2002-08-20 Verfahren zur Herstellung von Zeaxanthin und/oder dessen biosynthetischen Zwischen- und/oder Folgeprodukten
DE10238979 2002-08-20
DE2002138980 DE10238980A1 (de) 2002-08-20 2002-08-20 Verfahren zur Herstellung von Ketocarotinoiden in Blütenblättern von Pflanzen
DE10238978 2002-08-20
DE10238978A DE10238978A1 (de) 2002-08-20 2002-08-20 Verfahren zur Herstellung von Ketocarotinoiden in Früchten von Pflanzen
DE10253112 2002-11-13
DE2002153112 DE10253112A1 (de) 2002-11-13 2002-11-13 Verfahren zur Herstellung von Ketocarotinoiden in genetisch veränderten Organismen
DE2002158971 DE10258971A1 (de) 2002-12-16 2002-12-16 Verwendung von astaxanthinhaltigen Pflanzen oder Pflanzenteilen der Gattung Tagetes als Futtermittel
DE10258971 2002-12-16
PCT/EP2003/009105 WO2004018385A2 (fr) 2002-08-20 2003-08-18 Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques

Publications (1)

Publication Number Publication Date
EP1542945A2 true EP1542945A2 (fr) 2005-06-22

Family

ID=31950810

Family Applications (5)

Application Number Title Priority Date Filing Date
EP03792347A Withdrawn EP1542945A2 (fr) 2002-08-20 2003-08-18 Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques
EP03792350A Expired - Lifetime EP1531683B1 (fr) 2002-08-20 2003-08-18 Utilisation de plantes ou de parties de plantes contenant de l' astaxanthine du genre tagetes comme produit de fourrage
EP03792345A Withdrawn EP1532264A2 (fr) 2002-08-20 2003-08-18 Procede de production de cetocarotenoides dans les petales de plantes
EP03792348A Withdrawn EP1532265A2 (fr) 2002-08-20 2003-08-18 Procede d'obtention de cetocarotinoides dans des organismes genetiquement modifies
EP03792349A Withdrawn EP1532266A2 (fr) 2002-08-20 2003-08-18 Procede d'obtention de cetocarotinoides dans des fruits de plantes

Family Applications After (4)

Application Number Title Priority Date Filing Date
EP03792350A Expired - Lifetime EP1531683B1 (fr) 2002-08-20 2003-08-18 Utilisation de plantes ou de parties de plantes contenant de l' astaxanthine du genre tagetes comme produit de fourrage
EP03792345A Withdrawn EP1532264A2 (fr) 2002-08-20 2003-08-18 Procede de production de cetocarotenoides dans les petales de plantes
EP03792348A Withdrawn EP1532265A2 (fr) 2002-08-20 2003-08-18 Procede d'obtention de cetocarotinoides dans des organismes genetiquement modifies
EP03792349A Withdrawn EP1532266A2 (fr) 2002-08-20 2003-08-18 Procede d'obtention de cetocarotinoides dans des fruits de plantes

Country Status (12)

Country Link
US (5) US20060031963A1 (fr)
EP (5) EP1542945A2 (fr)
CN (1) CN1675367A (fr)
AT (1) ATE484198T1 (fr)
AU (5) AU2003253416A1 (fr)
CA (5) CA2496207A1 (fr)
DE (1) DE50313184D1 (fr)
IL (4) IL166507A0 (fr)
MX (5) MXPA05001899A (fr)
NO (5) NO20050598L (fr)
WO (5) WO2004018694A2 (fr)
ZA (1) ZA200602230B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532256A1 (fr) * 2002-08-20 2005-05-25 Sungene GmbH & Co. KGaA Procede de preparation de $g(b)-carotinoides
EP1542945A2 (fr) * 2002-08-20 2005-06-22 Sungene GmbH & Co. KGaA Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques
AU2003250193A1 (en) * 2002-08-20 2004-04-08 Sungene Gmbh & Co. Kgaa Transgenic expression cassettes for the expression of nucleic acids in plant blooms
EP1554388A1 (fr) * 2002-10-11 2005-07-20 Sungene GmbH & Co. KGaA Cassettes d'expression transgenique pour l'expression d'acides nucleiques dans une fleur vegetale
DE10300649A1 (de) * 2003-01-09 2004-07-22 Basf Ag Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Organismen
JP4803739B2 (ja) * 2004-06-04 2011-10-26 キリンホールディングス株式会社 カロテノイドケトラーゼ及びカロテノイドヒドロキシラーゼ遺伝子を利用したアスタキサンチンまたはその代謝物の製造法
UA94038C2 (ru) 2005-03-18 2011-04-11 Майкробиа, Инк. Продуцирование каротиноидов в маслянистых дрожжах и грибах
CA2614659A1 (fr) * 2005-07-11 2007-01-18 Commonwealth Scientific And Industrial Research Organisation Pigment de ble
WO2008042338A2 (fr) 2006-09-28 2008-04-10 Microbia, Inc. Production de caroténoïdes dans des levures et des champignons oléagineux
AU2007351787A1 (en) * 2006-10-20 2008-10-30 Arizona Board Of Regents For And On Behalf Of Arizona State University Modified cyanobacteria
BRPI0806029A2 (pt) * 2007-07-19 2009-11-10 Biosigma Sa plasmìdeos para transformação de bactérias do gênero aciditiobacillus spp. e método de transformação
US20090093015A1 (en) * 2007-10-09 2009-04-09 Kemin Foods, L.C. Beta-cryptoxanthin production using a novel lycopene beta-monocyclase gene
EP2199399A1 (fr) * 2008-12-17 2010-06-23 BASF Plant Science GmbH Production de cétocaroténoïdes dans les plantes
WO2010079032A1 (fr) * 2008-12-17 2010-07-15 Basf Plant Science Gmbh Production de cétocaroténoïdes dans des plantes
EP2742131B1 (fr) * 2011-08-08 2018-11-28 Evolva SA Procédés et matières pour la production recombinante de composés du safran
CN104093414A (zh) 2011-11-29 2014-10-08 神经噬菌体制药股份有限公司 噬菌体的p3作为淀粉样蛋白结合剂的用途
ES2558953B1 (es) * 2015-11-23 2016-11-18 Universitat De Lleida Maíz enriquecido en antioxidantes para mejorar la calidad nutricional del huevo
JP2019165635A (ja) 2016-08-10 2019-10-03 味の素株式会社 Ｌ−アミノ酸の製造法
US10004253B1 (en) * 2017-09-05 2018-06-26 Jose-Odon Torres-Quiroga Method for increasing the health condition of crustaceans in aquaculture, survival rate and pigmentation
CN112458103B (zh) * 2021-01-28 2022-09-30 青岛农业大学 一种调控辣椒红素积累的基因CaBBX20及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016012D0 (en) 1990-07-20 1990-09-05 Unilever Plc Pigments
DE69433969T2 (de) * 1993-12-27 2005-08-11 Kirin Beer K.K. Dna - kette zur synthese von xanthophyll und prozess zur herstellung von xanthophyll
US5916791A (en) * 1995-11-24 1999-06-29 Hirschberg; Joseph Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin
BR9713462A (pt) * 1996-08-09 2000-03-28 Calgene Inc Métodos para produção de compostos carotenóides e óleos especiais em sementes de plantas.
US6429356B1 (en) * 1996-08-09 2002-08-06 Calgene Llc Methods for producing carotenoid compounds, and specialty oils in plant seeds
US6221417B1 (en) * 1997-05-14 2001-04-24 Kemin Industries, Inc. Conversion of xanthophylls in plant material for use as a food colorant
US5876782A (en) * 1997-05-14 1999-03-02 Kemin Industries, Inc. Method for the conversion of xanthophylls in plant material
CA2333281A1 (fr) * 1998-05-22 1999-12-02 University Of Maryland Genes et produits geniques de cetolase de carotenoide, production de carotenoides et procedes permettant de modifier des carotenoides au moyen de ces genes
CA2330167A1 (fr) * 1998-06-02 1999-12-09 University Of Maryland Genes de la biosynthese et du metabolisme du carotenoide et techniques d'utilisation
US6232530B1 (en) * 1998-11-30 2001-05-15 University Of Nevada Marigold DNA encoding beta-cyclase
DE19916140A1 (de) * 1999-04-09 2000-10-12 Basf Ag Carotinhydroxylase und Verfahren zur Herstellung von Xanthophyllderivaten
SE9903336D0 (sv) 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
US20050003474A1 (en) * 2001-01-26 2005-01-06 Desouza Mervyn L. Carotenoid biosynthesis
DE10201458A1 (de) * 2001-04-11 2002-10-17 Adelbert Bacher Intermediate und Enzyme des Mevalonat-unabhängigen Isoprenoidbiosyntheseweg
US6784351B2 (en) * 2001-06-29 2004-08-31 Ball Horticultural Company Targetes erecta marigolds with altered carotenoid compositions and ratios
US7575766B2 (en) * 2001-06-29 2009-08-18 Ball Horticultural Company Tagetes erecta with altered carotenoid compositions and ratios
US6372946B1 (en) * 2001-09-13 2002-04-16 Prodemex, S.A. De C.V. Preparation of 4,4′-diketo-β-carotene derivatives
US7383788B2 (en) * 2002-03-11 2008-06-10 Dsm Ip Assets B.V. Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract
US7223909B2 (en) * 2002-03-21 2007-05-29 Ball Horticultural 4-ketocarotenoids in flower petals
EP1542945A2 (fr) * 2002-08-20 2005-06-22 Sungene GmbH & Co. KGaA Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques
DE10300649A1 (de) * 2003-01-09 2004-07-22 Basf Ag Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Organismen
DE102004007623A1 (de) * 2004-02-17 2005-08-25 Sungene Gmbh & Co. Kgaa Promotoren zur Expression von Genen in Tagetes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004018385A2 *

Also Published As

Publication number Publication date
WO2004017749A2 (fr) 2004-03-04
CA2495235A1 (fr) 2004-03-04
ZA200602230B (en) 2007-05-30
WO2004018385A3 (fr) 2004-10-21
IL166507A0 (en) 2006-01-15
EP1532266A2 (fr) 2005-05-25
EP1531683A2 (fr) 2005-05-25
US7385123B2 (en) 2008-06-10
NO20050598L (no) 2005-04-07
WO2004018693A2 (fr) 2004-03-04
DE50313184D1 (de) 2010-11-25
AU2003258623A1 (en) 2004-03-11
WO2004018695A3 (fr) 2004-10-14
CA2495878A1 (fr) 2004-03-04
NO20050704L (no) 2005-05-13
MXPA05001948A (es) 2005-09-08
US20060031963A1 (en) 2006-02-09
MXPA05001659A (es) 2005-07-22
EP1532264A2 (fr) 2005-05-25
US7381541B2 (en) 2008-06-03
NO20050703L (no) 2005-05-09
IL166771A0 (en) 2006-01-15
WO2004018693A3 (fr) 2004-12-09
IL166770A0 (en) 2006-01-15
CA2496133A1 (fr) 2004-03-04
CN1675367A (zh) 2005-09-28
WO2004018694A2 (fr) 2004-03-04
US20060112451A1 (en) 2006-05-25
AU2003260424A1 (en) 2004-03-11
US20060253927A1 (en) 2006-11-09
CA2495444A1 (fr) 2004-03-04
NO20050705L (no) 2005-05-18
WO2004018695A2 (fr) 2004-03-04
IL166767A0 (en) 2006-01-15
EP1532265A2 (fr) 2005-05-25
EP1531683B1 (fr) 2010-10-13
WO2004018694A3 (fr) 2004-09-10
AU2003264062B2 (en) 2008-01-03
WO2004017749A3 (fr) 2004-10-14
MXPA05001811A (es) 2005-10-19
US20070094749A1 (en) 2007-04-26
ATE484198T1 (de) 2010-10-15
AU2003264062A1 (en) 2004-03-11
NO20050755L (no) 2005-05-19
CA2496207A1 (fr) 2004-03-04
AU2003253416A1 (en) 2004-03-11
AU2003260423A1 (en) 2004-03-11
MXPA05001944A (es) 2005-06-22
US20050281909A1 (en) 2005-12-22
MXPA05001899A (es) 2005-08-29
WO2004018385A2 (fr) 2004-03-04

Similar Documents

Publication Publication Date Title
EP1542945A2 (fr) Procede de fabrication de zeaxanthine et/ou de ses produits intermediaires et/ou produits ses produits secondaires biosynthetiques
DE10300649A1 (de) Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Organismen
WO2010079032A1 (fr) Production de cétocaroténoïdes dans des plantes
DE10238980A1 (de) Verfahren zur Herstellung von Ketocarotinoiden in Blütenblättern von Pflanzen
DE102004007622A1 (de) Verfahren zur Herstellung von Ketocarotinoiden in genetisch veränderten, nicht-humanen Organismen
EP1532256A1 (fr) Procede de preparation de $g(b)-carotinoides
DE10258971A1 (de) Verwendung von astaxanthinhaltigen Pflanzen oder Pflanzenteilen der Gattung Tagetes als Futtermittel
DE10238979A1 (de) Verfahren zur Herstellung von Zeaxanthin und/oder dessen biosynthetischen Zwischen- und/oder Folgeprodukten
DE102004007624A1 (de) Neue Ketolasen und Verfahren zur Herstellung von Ketocarotinoiden
DE10238978A1 (de) Verfahren zur Herstellung von Ketocarotinoiden in Früchten von Pflanzen
DE10253112A1 (de) Verfahren zur Herstellung von Ketocarotinoiden in genetisch veränderten Organismen
EP1658372A2 (fr) Nouvelles cetolases et procede de production de cetocarotenoides
EP1658377A1 (fr) Procede de production de cetocarotenoides dans des organismes non humains genetiquement modifies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050421

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20071120

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080401